37941-69-8 Usage
Description
4-Hydroxy-N-methylbutyramide is an organic compound that serves as a key intermediate in the synthesis of potential hypotensive agents. It is characterized by its amide functional group and a hydroxyl group attached to a butyramide structure, which contributes to its pharmacological properties.
Uses
Used in Pharmaceutical Industry:
4-Hydroxy-N-methylbutyramide is used as an intermediate in the synthesis of hypotensive agents for the treatment of high blood pressure. Its chemical structure allows for the development of drugs that can effectively manage blood pressure levels, providing a valuable contribution to the pharmaceutical industry's efforts in combating hypertension.
As an intermediate, 4-Hydroxy-N-methylbutyramide plays a crucial role in the production of hypotensive medications, which are essential for maintaining cardiovascular health and preventing related complications such as stroke, heart attack, and kidney disease. Its application in this field highlights the importance of organic chemistry in the development of life-saving medications.
Check Digit Verification of cas no
The CAS Registry Mumber 37941-69-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,9,4 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 37941-69:
(7*3)+(6*7)+(5*9)+(4*4)+(3*1)+(2*6)+(1*9)=148
148 % 10 = 8
So 37941-69-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO2/c1-6-5(8)3-2-4-7/h7H,2-4H2,1H3,(H,6,8)
37941-69-8Relevant articles and documents
RAPAMYCIN ANALOGS AND USES THEREOF
-
Paragraph 00549-00550, (2020/01/08)
The present invention provides compounds, compositions thereof, and methods of using the same.
A Study on the Intramolecular Mitsunobu Reaction of N6-(ω-Hydroxyalkyl)adenines
?im?nková, Nadě?da,Tobrman, Tomá?,Eigner, Václav,Dvo?ák, Dalimil
, p. 3565 - 3573 (2017/11/21)
The cyclization of N6-(ω-hydroxyalkyl)adenines with a N6H-group leads to N6,N1 ring closure regardless of the method of the cyclization that was used. Five-membered to eight-membered rings were obtained using NBS/PPh3; however, under Mitsunobu conditions, the eight-membered fused purine was not formed. Surprisingly, the cyclization of N6-methyl-N6-(4-hydroxybutyl)adenine only leads to N6,N7 ring closure using both methods.
A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases
-
Page/Page column 7, (2011/11/01)
A dinitrate ester of a valsartanamide is described. It has superior properties in the treatment of vascular and metabolic diseases.